Shares of Pfizer Inc. PFE shed 3.49% to $21.84 Tuesday, on what proved to be an all-around poor trading session for the stock ...

Pfizer stock fell to the lowest closing price since 2012, putting its yield near 8%, after cautious comments from a UBS ...

Here is why it could be a smart buy now. Not every stock needs to be a millionaire-maker. Sometimes, slow and steady can win ...

Eli Lilly (LLY) stock and Johnson & Johnson (JNJ) stock are upgraded and Pfizer (PFE) stock and AbbVie (ABBV) stock downgraded at Goldman Sachs. Read more here.

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of ...

Goldman Sachs downgraded Pfizer (PFE) to Neutral from Buy with a price target of $25, down from $32, after assuming coverage of the name. The ...

A new report by MyHome and the Bank of Ireland suggests the Irish economy’s dependence on U.S. multinationals could lead to a ...

These five well-known dividend stocks were beaten down in the recent selling but will remain attractive long after the tariff ...

Pfizer’s blockbuster COVID era has officially left the chat, but the pharmaceutical giant is scripting a bold new chapter.